|Videos|November 26, 2013
Episode 10 - End-of-Life Care in CRPC
Advertisement
Episodes in this series
During this segment, the panelists consider the variables and programs that assist healthcare professionals who counsel and care for patients during end-of-life scenarios.
Jeffrey D. Dunn, PharmD, MBA, considers managed care’s role during end-of-life scenarios.
David Quinn, MD, explains when and how he discusses end-of-life care to his patients. He highlights the challenges that he faces and emphasizes the importance for integrated care between healthcare professionals.
Michael Kolodziej, MD, explains how the goals set forth by healthcare reform affect end-of-life care, and highlights the benefits of Aetna’s Compassionate Care program for patients in hospice.
Advertisement
Related to this article
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
Cepheid's Connie Savor, MD, MBA, explains where its 13-pathogen respiratory panel fits in diagnostic stewardship and antibiotic decisions.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
The FDA approves atezolizumab with a fluoropyrimidine and oxaliplatin as adjuvant therapy for stage III dMMR colon cancer based on the ATOMIC trial.
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
3
GLP-1s Have Protective Benefit Against DME, Glaucoma Surgery
4
Keynote Address Tackles AI’s Role in Health Care, Eye Care
5